Ovarian cancer in younger vs older women: a population-based analysis

To compare the clinico-pathologic prognostic factors and survival of younger vs older women diagnosed with epithelial ovarian cancer. Demographic, clinico-pathologic, treatment, and surgery information were obtained from patients with ovarian cancer from the Surveillance, Epidemiology, and End Resul...

Full description

Saved in:
Bibliographic Details
Published in:British journal of cancer 2006-11, Vol.95 (10), p.1314-1320
Main Authors: Chan, J K, Urban, R, Cheung, M K, Osann, K, Husain, A, Teng, N N, Kapp, D S, Berek, J S, Leiserowitz, G S
Format: Article
Language:English
Subjects:
Adenocarcinoma, Clear Cell - epidemiology
Adenocarcinoma, Clear Cell - mortality
Adenocarcinoma, Clear Cell - surgery
Adult
Age Factors
Aged
Aged, 80 and over
Biological and medical sciences
Biomedical and Life Sciences
Biomedicine
Cancer Research
Case-Control Studies
Clinical Study
Cohort Studies
Drug Resistance
Epidemiology
Female
Female genital diseases
Gynecology. Andrology. Obstetrics
Humans
Medical sciences
Middle Aged
Molecular Medicine
Neoplasms, Glandular and Epithelial - epidemiology
Neoplasms, Glandular and Epithelial - mortality
Neoplasms, Glandular and Epithelial - surgery
Oncology
Ovarian cancer
Ovarian Neoplasms - epidemiology
Ovarian Neoplasms - mortality
Ovarian Neoplasms - surgery
Prognosis
SEER Program
Survival Rate
Tumors
United States - epidemiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To compare the clinico-pathologic prognostic factors and survival of younger vs older women diagnosed with epithelial ovarian cancer. Demographic, clinico-pathologic, treatment, and surgery information were obtained from patients with ovarian cancer from the Surveillance, Epidemiology, and End Results Program from 1988 to 2001 and analysed using Kaplan–Meier estimates. Of 28 165 patients, 400 were 60 (older) years of age. Of the very young, young, and older patients, 261 (65.3%), 4664 (40.2%), and 3643 (22.5%) had stage I–II disease, respectively ( P
ISSN:0007-0920
1532-1827
DOI:10.1038/sj.bjc.6603457